ritonavir booster
Selected indexed studies
- Ritonavir. (, 2026) [PMID:31335032]
- Ombitasvir. (, 2006) [PMID:29999879]
- Therapeutics for COVID-19. (Nat Microbiol, 2023) [PMID:37142688]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Dasabuvir. (2006) pubmed
- Ritonavir. (2026) pubmed
- Ombitasvir. (2006) pubmed
- Therapeutics for COVID-19. (2023) pubmed
- Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIV. (2025) pubmed
- Paritaprevir. (2006) pubmed
- Influence of a Short Course of Ritonavir Used as Booster in Antiviral Therapies Against SARS-CoV-2 on the Exposure of Atorvastatin and Rosuvastatin. (2025) pubmed
- Nirmatrelvir plus ritonavir in COVID-19: a profile of its use. (2023) pubmed
- Ritonavir's Evolving Role: A Journey from Antiretroviral Therapy to Broader Medical Applications. (2024) pubmed
- Development and validation of a population pharmacokinetic model for ritonavir used as a booster or as an antiviral agent in HIV-1-infected patients. (2005) pubmed